NCT00127283
- Conditions
- Acquired Bleeding Disorder, Brain Diseases, Cardiovascular Diseases, +10 more
- Locations
-
- Novo Nordisk Investigational Site Birmingham, Alabama, United States
- Novo Nordisk Investigational Site Mobile, Alabama, United States
- Novo Nordisk Investigational Site Phoenix, Arizona, United States
- Novo Nordisk Investigational Site Fort Smith, Arkansas, United States